AllianceBernstein’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.9M Sell
518,346
-1,171,856
-69% -$77M 0.01% 714
2026
Q1
$139M Sell
1,690,202
-181,942
-10% -$14.3M 0.04% 286
2025
Q4
$154M Sell
1,872,144
-2,431,005
-56% -$189M 0.05% 279
2025
Q3
$323M Sell
4,303,149
-869,244
-17% -$64.8M 0.1% 155
2025
Q2
$383M Sell
5,172,393
-786,315
-13% -$54.7M 0.13% 135
2025
Q1
$481M Sell
5,958,708
-168,961
-3% -$14.5M 0.17% 105
2024
Q4
$479M Sell
6,127,669
-220,133
-3% -$18.7M 0.16% 106
2024
Q3
$596M Sell
6,347,802
-494,738
-7% -$41.5M 0.2% 90
2024
Q2
$533M Buy
6,842,540
+886,105
+15% +$72.3M 0.19% 96
2024
Q1
$541M Buy
5,956,435
+4,259,908
+251% +$354M 0.19% 100
2023
Q4
$131M Buy
1,696,527
+1,094,003
+182% +$76.6M 0.05% 318
2023
Q3
$41M Buy
602,524
+24,772
+4% +$1.8M 0.02% 614
2023
Q2
$46.9M Buy
577,752
+103,340
+22% +$8.25M 0.02% 598
2023
Q1
$38.9M Buy
+474,412
New +$33.9M 0.02% 631

Other funds holding GEHC

AllianceBernstein's GEHC Position: Q2 2026 in Review

AllianceBernstein reduced its GE HealthCare (GEHC) stake by 69% in Q2 2026, selling an estimated $77M and leaving 518,346 shares worth $36.9M. The position accounts for 0.01% of the portfolio, ranked #714.

AllianceBernstein first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $596M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • AllianceBernstein held 518,346 shares of GE HealthCare worth $36.9M as of Q2 2026.
  • AllianceBernstein sold 1,171,856 GE HealthCare shares in Q2 2026, an estimated $77M.
  • GE HealthCare made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #714 holding.
  • AllianceBernstein first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • AllianceBernstein's GE HealthCare position peaked at $596M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.